Metropolitan Life Insurance Company (MetLife)’s MiMedx Group MDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,734
| Closed | -$51.9K | – | 1256 |
|
|
2024
Q1 | $51.9K | Hold |
6,734
| – | – | ﹤0.01% | 1385 |
|
|
2023
Q4 | $59.1K | Hold |
6,734
| – | – | ﹤0.01% | 1356 |
|
|
2023
Q3 | $49.1K | Buy |
6,734
+512
| +8% | +$3.81K | ﹤0.01% | 1418 |
|
|
2023
Q2 | $41.1K | Buy |
6,222
+1,751
| +39% | +$8.93K | ﹤0.01% | 1539 |
|
|
2023
Q1 | $15.2K | Sell |
4,471
-2,375
| -35% | -$9.2K | ﹤0.01% | 2005 |
|
|
2022
Q4 | $19K | Hold |
6,846
| – | – | ﹤0.01% | 2044 |
|
|
2022
Q3 | $19.6K | Buy |
6,846
+2,121
| +45% | +$7.54K | ﹤0.01% | 2038 |
|
|
2022
Q2 | $16.4K | Sell |
4,725
-2,708
| -36% | -$10.6K | ﹤0.01% | 2134 |
|
|
2022
Q1 | $35K | Sell |
7,433
-15,806
| -68% | -$77.3K | ﹤0.01% | 1796 |
|
|
2021
Q4 | $140K | Buy |
23,239
+3,001
| +15% | +$20.8K | ﹤0.01% | 2260 |
|
|
2021
Q3 | $123K | Sell |
20,238
-11,255
| -36% | -$127K | ﹤0.01% | 2407 |
|
|
2021
Q2 | $394K | Buy |
+31,493
| New | +$341K | 0.01% | 1683 |
|
|
2018
Q4 | – | Sell |
-35,076
| Closed | -$217K | – | 2563 |
|
|
2018
Q3 | $217K | Hold |
35,076
| – | – | ﹤0.01% | 1953 |
|
|
2018
Q2 | $224K | Buy |
+35,076
| New | +$250K | ﹤0.01% | 1872 |
|
|
2018
Q1 | – | Sell |
-34,284
| Closed | -$399K | – | 1767 |
|
|
2017
Q4 | $432K | Sell |
34,284
-35,643
| -51% | -$435K | 0.01% | 1389 |
|
|
2017
Q3 | $831K | Sell |
69,927
-1,095
| -2% | -$16.2K | 0.01% | 1362 |
|
|
2017
Q2 | $1.06M | Hold |
71,022
| – | – | 0.01% | 1218 |
|
|
2017
Q1 | $677K | Buy |
71,022
+2,649
| +4% | +$22.4K | ﹤0.01% | 1452 |
|
|
2016
Q4 | $606K | Sell |
68,373
-11,667
| -15% | -$105K | ﹤0.01% | 1609 |
|
|
2016
Q3 | $687K | Sell |
80,040
-3,954
| -5% | -$31.3K | 0.01% | 1500 |
|
|
2016
Q2 | $670K | Hold |
83,994
| – | – | 0.01% | 1508 |
|
|
2016
Q1 | $734K | Buy |
83,994
+9,585
| +13% | +$79.7K | 0.01% | 1337 |
|
|
2015
Q4 | $697K | Buy |
74,409
+2,486
| +3% | +$21.5K | 0.01% | 1405 |
|
|
2015
Q3 | $694K | Sell |
71,923
-3,065
| -4% | -$32.4K | 0.01% | 1410 |
|
|
2015
Q2 | $869K | Sell |
74,988
-1,330
| -2% | -$13.7K | 0.01% | 1383 |
|
|
2015
Q1 | $794K | Hold |
76,318
| – | – | 0.01% | 1335 |
|
|
2014
Q4 | $880K | Sell |
76,318
-1,480
| -2% | -$14.6K | 0.01% | 1409 |
|
|
2014
Q3 | $555K | Hold |
77,798
| – | – | ﹤0.01% | 1658 |
|
|
2014
Q2 | $552K | Hold |
77,798
| – | – | ﹤0.01% | 1767 |
|
|
2014
Q1 | $477K | Hold |
77,798
| – | – | ﹤0.01% | 1838 |
|
|
2013
Q4 | $680K | Buy |
77,798
+2,278
| +3% | +$13.9K | ﹤0.01% | 1600 |
|
|
2013
Q3 | $315K | Sell |
75,520
-2,718
| -3% | -$15K | ﹤0.01% | 2071 |
|
|
2013
Q2 | $552K | Buy |
+78,238
| New | +$547K | ﹤0.01% | 1633 |
|
Other funds holding MDXG
EWM
TI
PCMI
CC
Metropolitan Life Insurance Company (MetLife)'s MDXG Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of MiMedx Group (MDXG) in Q2 2024, closing a stake of 6,734 shares — an estimated $51.9K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in MDXG in Q2 2013 and held it in 33 quarters. The position peaked at $1.06M in Q2 2017. 202 funds tracked by Wall St. Rank hold MDXG as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining MiMedx Group position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 6,734 MiMedx Group shares in Q2 2024, an estimated $51.9K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in MiMedx Group in Q2 2013 and held it in 33 quarters.
- Metropolitan Life Insurance Company (MetLife)'s MiMedx Group position peaked at $1.06M in Q2 2017.
- 202 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.